Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Houston, Louisiana Clinical Trials

A listing of Houston, Louisiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (21) clinical trials

A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib.

Phase

0.27 miles

Learn More »

A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)

Study Groups: If you are found to be eligible to take part in this study, you will be assigned to Group 1 and receive apalutamide, abiraterone, and prednisone. After 8 weeks of receiving treatment in Group 1, you will then have blood (about 4 teaspoons) drawn for biomarker testing. The ...

Phase

4.11 miles

Learn More »

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma

This is a multicenter trial to evaluate Pembrolizumab for patients with advanced penile squamous cell carcinoma following prior chemotherapy. Participating institutions are the University of Alabama at Birmingham (coordinating center), M.D. Anderson Cancer Center, University of Michigan, University of Minnesota, and Emory University. Patients will receive intravenous Pembrolizumab every 3 ...

Phase

4.11 miles

Learn More »

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis

The primary objective of this study is to evaluate the testicular safety of filgotinib in adult males with moderately to severely active ulcerative colitis.

Phase

4.11 miles

Learn More »

Tremelimumab + Durvalumab Chemotherapy Naive CRPC

Study Drug Administration: Each study cycle is 28 days. If you are found to be eligible to take part in this study, you will receive tremelimumab by vein over 60 minutes on Day 1 of Cycles 1-4. You will not receive tremelimumab after Cycle 4. You will also receive durvalumab ...

Phase

4.11 miles

Learn More »

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in a roll of dice) to 1 of 2 study groups. This is done because no one knows if one study group is better, the same, or worse than ...

Phase

4.11 miles

Learn More »

Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence

Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one study group is better, the same, or worse ...

Phase

4.11 miles

Learn More »

Neoadjuvant Axitinib in Prostate Cancer

Study Groups If you are found to be eligible to take part in this study, you will be randomly assigned (as in the roll of the dice) to 1 of 2 groups: If you are in Group A, you will receive axitinib and hormonal therapy. If you are in Group ...

Phase

4.11 miles

Learn More »

A Randomized Phase 2 Trial of Combining Sipuleucel-T With Immediate vs. Delayed CTLA-4 Blockade for Prostate Cancer

This is an open-label randomized multicenter Phase 2 clinical trial combining SipT with ipilimumab in patients with chemotherapy-nave metastatic castration resistant prostate cancer (CRPC). All patients will be treated with standard SipT (Q2wks x 3). Patients will be randomized to one of two arms: Arm 1 (Immediate Treatment): Ipilimumab Q3wks ...

Phase

4.11 miles

Learn More »

H-22411: BOTOX for Peyronie's Disease

Treatments for this disease have been limited and often unsuccessful. The goal of treatment is to reduce pain and maintain sexual function. Oral medicines that prevent plaque formation and promote plaque breakdown have not been effective. Many patients with the disease will require injections of medicines directly into the plaque. ...

Phase

4.11 miles

Learn More »